VeriMomVeriMom

fullerenes hamilelikte güvenli mi?

Animal and toxicology studies report maternal–fetal distribution of C60 and adverse effects on placental development and fetal outcomes for some fullerene formulations/derivatives (e.g., PVP‑C60, fullerenols), supporting suspected reproductive/developmental hazard (NTP toxicology report; rodent studies). No EU Annex II ban or harmonised CLP H360/H361 classification was found for CAS 99685‑96‑8, so classification is based on animal evidence rather than harmonised legal classification. ([ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/books/NBK561354/?utm_source=openai))

İçerikler
fullerenes
ORTA RISK
40
/100
0

Hamilelikte fullerenes yerine kullanılabilecek güvenli alternatifler | VeriMom

Related ingredients

Frequently asked questions

fullerenes hamilelikte güvenli mi?
Animal and toxicology studies report maternal–fetal distribution of C60 and adverse effects on placental development and fetal outcomes for some fullerene formulations/derivatives (e.g., PVP‑C60, fullerenols), supporting suspected reproductive/developmental hazard (NTP toxicology report; rodent studies). No EU Annex II ban or harmonised CLP H360/H361 classification was found for CAS 99685‑96‑8, so classification is based on animal evidence rather than harmonised legal classification. ([ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/books/NBK561354/?utm_source=openai))
fullerenes emzirirken güvenli mi?
Mechanistic and animal data show maternal distribution of C60 to reproductive tissues and placenta; by analogy there is plausible transfer to milk or neonatal exposure for some formulations, though direct lactation studies are limited. Dermal cosmetic use yields low but measurable exposure; therefore breastfeeding risk is suspected where formulations enable systemic uptake. ([ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/books/NBK561354/?utm_source=openai))
fullerenes bebek cildi için güvenli mi?
Fullerenes are used in cosmetics (C60/C70 and derivatives detected in commercial products). Nanoparticles can penetrate or be more bioavailable on immature infant skin; because animal studies show developmental/placental effects for some forms, and topical products can contain measurable amounts, infant skin exposure is of greater concern (exposure score increased by +1 for infants). Direct infant dermal studies are lacking. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3725139/?utm_source=openai))
VeriMom fullerenes nasıl puanlıyor?
VeriMom fullerenes'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 40/100 (orta risk) olarak puanlar.
Hamilelikte fullerenes yerine neler kullanılabilir?
Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.

Her etiketi 2 saniyede kontrol et

VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.

Tıbbi Sorumluluk Reddi

Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.

VeriMom uygulamasında tüm özellikleri keşfedin